Filtered By:
Vaccination: Meningitis Vaccine
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 2891 results found since Jan 2013.
The role of pneumococcal vaccination in reducing the cardiovascular risk of cardiac patients: opinion of experts of the Prevention Committee of the Polish Cardiac Society supported by the Polish Vaccinology Society
Kardiol Pol. 2023 Sep 3. doi: 10.33963/v.kp.96718. Online ahead of print.ABSTRACTRespiratory diseases have been the fourth most common cause of death in Poland in recent years. Respiratory infection, especially pneumonia, can lead to exacerbation of chronic cardiovascular disease. Streptococcus pneumoniae is the most common bacterial pathogen causing community-acquired pneumonia. Pneumococci are also the most common pathogen complicating the course of influenza virus infection. Pneumonia, especially invasive pneumococcal disease, is associated with the risk of death in the course of respiratory failure or sepsis and also w...
Source: Kardiologia Polska - September 3, 2023 Category: Cardiology Authors: Artur Mamcarz Marcin We łnicki Jaros ław Drożdż Marcin Grabowski Piotr Jankowski Ernest Kuchar Przemys ław Leszek Przemys ław Mitkowski Jacek Wysocki Source Type: research
Antibodies against Neisseria meningitidis serogroups A, C, W and Y in serum and saliva of Norwegian adolescents
CONCLUSION: Unvaccinated adolescents in Norway have a low degree of natural immunity against the serogroups of N. meningitidis predominating among cases of IMD in this age group. Therefore, introduction of MCV4 for adolescents in the NIP is recommended.PMID:37648606 | DOI:10.1016/j.vaccine.2023.08.052
Source: Vaccine - August 30, 2023 Category: Allergy & Immunology Authors: Sara Viksmoen Watle Bente B ørud Ida Laake Marta Baranowska-Hustad Diane Bryant-Bratlie Terese Bekkevold Dominique A Caugant Gro Tunheim Lisbeth Meyer N æss Source Type: research
Exploring missed opportunities for influenza vaccination and influenza vaccine co-administration patterns among Italian older adults: a retrospective cohort study
CONCLUSIONS: A sizeable proportion of older adults who received other recommended vaccines during the last influenza season did not receive SIV. This share of missed opportunities, which are subject to some social inequalities, may be addressed by increasing vaccine co-administration rates and implementing tailored health promotion interventions.PMID:37632235 | DOI:10.1093/eurpub/ckad155
Source: Herpes - August 26, 2023 Category: Infectious Diseases Authors: Alexander Domnich Andrea Orsi Matilde Ogliastro Carlo-Simone Trombetta Marianna Scarpaleggia Chiara Ceccaroli Carla Amadio Anna Raffo Luca Berisso Alla Yakubovich Giacomo Zappa Daniela Amicizia Donatella Panatto Giancarlo Icardi Source Type: research
Erratum to "Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study" Vaccine 41(1) (2023) 85-91
Vaccine. 2023 Aug 23:S0264-410X(23)00870-8. doi: 10.1016/j.vaccine.2023.07.039. Online ahead of print.NO ABSTRACTPMID:37625991 | DOI:10.1016/j.vaccine.2023.07.039
Source: Vaccine - August 25, 2023 Category: Allergy & Immunology Authors: Nusrat Homaira Roxanne Strachan Helen Quinn Sean Beggs Mejbah Bhuiyan Asha Bowen Laura K Fawcett Gwendolyn L Gilbert Stephen B Lambert Kristine Macartney Helen S Marshall Andrew C Martin Gabrielle McCallum Angela McCullagh Tim McDonald Hiran Selvadurai Pe Source Type: research
Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study
CONCLUSIONS: PCV13 vaccination among children aged 0-5 years substantially reduced the incidence of all-cause pneumonia. Direct immunization of children under 5 years is an effective strategy to combat outpatient pneumonia, and hospitalized pneumonia.PMID:37620204 | DOI:10.1016/j.vaccine.2023.08.041
Source: Vaccine - August 24, 2023 Category: Allergy & Immunology Authors: Jie Tian Bo Zheng Laibao Yang Ying Guan Chunze Xu Weibing Wang Source Type: research
Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2022
MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):912-919. doi: 10.15585/mmwr.mm7234a3.ABSTRACTThree vaccines are routinely recommended for adolescents to prevent pertussis, meningococcal disease, and cancers caused by human papillomavirus (HPV). CDC analyzed data from the 2022 National Immunization Survey-Teen for 16,043 adolescents aged 13-17 years to assess vaccination coverage. Birth cohort analyses were conducted to assess trends in vaccination coverage by age 13 years (i.e., before the 13th birthday) and by age 14 years (i.e., before the 14th birthday) among adolescents who were due for routine vaccination before and dur...
Source: MMWR Morb Mortal Wkl... - August 24, 2023 Category: Epidemiology Authors: Cassandra Pingali David Yankey Laurie D Elam-Evans Lauri E Markowitz Madeleine R Valier Benjamin Fredua Samuel J Crowe Carla L DeSisto Shannon Stokley James A Singleton Source Type: research
Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study
CONCLUSIONS: PCV13 vaccination among children aged 0-5 years substantially reduced the incidence of all-cause pneumonia. Direct immunization of children under 5 years is an effective strategy to combat outpatient pneumonia, and hospitalized pneumonia.PMID:37620204 | DOI:10.1016/j.vaccine.2023.08.041
Source: Vaccine - August 24, 2023 Category: Allergy & Immunology Authors: Jie Tian Bo Zheng Laibao Yang Ying Guan Chunze Xu Weibing Wang Source Type: research
Pneumococcal Vaccination in Adults
Am J Nurs. 2023 Sep 1;123(9):48-51. doi: 10.1097/01.NAJ.0000978148.47780.7f.ABSTRACTThe Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recently updated the adult pneumococcal vaccine recommendations to include two new pneumococcal conjugate vaccines (PCVs): PCV15 and PCV20. The authors review the updated guideline recommendations, their advantages and disadvantages, and nursing implications.PMID:37615467 | DOI:10.1097/01.NAJ.0000978148.47780.7f
Source: The American Journal of Nursing - August 24, 2023 Category: Nursing Authors: Joseph Walter Nicole Rudawsky Source Type: research
Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2022
MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):912-919. doi: 10.15585/mmwr.mm7234a3.ABSTRACTThree vaccines are routinely recommended for adolescents to prevent pertussis, meningococcal disease, and cancers caused by human papillomavirus (HPV). CDC analyzed data from the 2022 National Immunization Survey-Teen for 16,043 adolescents aged 13-17 years to assess vaccination coverage. Birth cohort analyses were conducted to assess trends in vaccination coverage by age 13 years (i.e., before the 13th birthday) and by age 14 years (i.e., before the 14th birthday) among adolescents who were due for routine vaccination before and dur...
Source: MMWR Morb Mortal Wkl... - August 24, 2023 Category: Epidemiology Authors: Cassandra Pingali David Yankey Laurie D Elam-Evans Lauri E Markowitz Madeleine R Valier Benjamin Fredua Samuel J Crowe Carla L DeSisto Shannon Stokley James A Singleton Source Type: research
